Katie Wakeley

<i>BRCA1</i> and <i>BRCA2</i> mutations account for a large proportion of ovarian carcinoma cases

Tuya Pal, Jenny Permuth‐Wey, Judith A. Betts et al. · Cancer · 2005 · 691 citations

Life Sciences, Genetics, Oncology +14

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Antonis C. Antoniou, Xianshu Wang, Zachary S. Fredericksen et al. · Nature Genetics · 2010 · 342 citations · Full text

Medicine, Genetics, Oncology +17

Lysophospholipids Are Potential Biomarkers of Ovarian Cancer

Rebecca Sutphen, Yan Xu, George D. Wilbanks et al. · Cancer Epidemiology Biomarkers & Prevention · 2004 · 337 citations

Medicine, Gynecology, Oncology +16

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction

Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog et al. · Cancer Research · 2010 · 184 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

Steven J. Skates, Mark H. Greene, Saundra S. Buys et al. · Clinical Cancer Research · 2017 · 139 citations · Full text

Medicine, Gynecology, Oncology +17